GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (OTCPK:MDGEF) » Definitions » Short Ratio

MDGEF (Medigene AG) Short Ratio


View and export this data going back to 2013. Start your Free Trial

What is Medigene AG Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Medigene AG Business Description

Address
Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG Headlines

From GuruFocus

Q4 2020 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2023 Medigene AG Earnings Call Transcript

By GuruFocus Research 03-29-2024

Q2 2023 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Medigene AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 Medigene AG Earnings Call Transcript

By GuruFocus Research 08-15-2024